GlaxoSmithKline(GB:GSK)
GBX 1,911.50+10.50 (+0.55%)
GB:GSK
GlaxoSmithKline Revenue
GBX 1,911.50
At close:+10.50 (+0.55%)
Want to see GB:GSK full AI Analyst Report?
GlaxoSmithKline (GSK) Revenue
1,178 Followers
GlaxoSmithKline Revenue
GlaxoSmithKline had a revenue of 8.89B in the quarter ending Sep 30, 2026, with 5.68%. This bring the company's revenue in the last twelve months to 33.54B, Increased 1.02%. In the fiscal year ending Dec 31, 2025, GlaxoSmithKline had annual revenue of 32.67B with 4.11% growth.
- Revenue (ttm)
- 33.54B
- Revenue Growth
- 4.28%
- P/S Ratio
- 2.35
- Revenue/Employee
- GBP 488,727
- Employees
- 66,841
- Market Cap
- GBP 76.63B
Revenue Chart
GlaxoSmithKline Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | -9.40B | -27.58% |
| Dec 31, 2020 | 34.10B | 345.00M | 1.02% |
| Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
| Dec 31, 2018 | 30.82B | 635.00M | 2.10% |
| Dec 31, 2017 | 30.19B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.